VERSANT Zika RNA 1.0 Assay (kPCR)

Qualitative detection for Zika virus

Excellent Assay Performance

  • High-specificity (no cross-reactivity with other Flaviviruses)
  • Dual-target design improves detection
  • Amplifies and detects all currently identified Zika genotypes: West African (Nigerian cluster), East African (MR766 prototype cluster), and Asian
  • Good specificity when tested against cross-reactive species and high sensitivity with commercially available Zika cultures.


Sample Handling Simplicity

  • Validated for serum, plasma, or urine (collected alongside a patient-matched serum or plasma specimen)
  • 48 tests per kit
  • Internal control (IC) to monitor RNA extraction and PCR efficiency
  • Includes UNG for contamination control


Workflow Efficiency

  • Validated for multiple thermal cyclers (THERMO FISHER QuantStudio 5, BIO-RAD CFX96, and ABI 7500 Fast Dx)
  • Concordant with CDC Zika assay using a variety of patient-matched clinical samples (plasma, serum, and urine)**


**Internal data on file.

VERSANT and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc. All other trademarks and brands are the property of their respective owners. Product availability varies and is subject to country specific regulatory requirements. Please contact your local Siemens organization for further details.

Did this information help you ?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you